Sultana, R., Robinson, R., Di Domenico, F., Abdul, H., St Clair, D., Markesbery, W., … Butterfield, D. (2011). Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. Journal of Proteomics, 74(11), 2430-40. https://doi.org/10.1016/j.jprot.2011.06.015 (Original work published 2011)
WR Markesbery
First name:
WR
Last name:
Markesbery
Yatin, S., Aksenova, M., Aksenov, M., Markesbery, W., Aulick, T., & Butterfield, D. (1998). Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. Journal of Molecular Neuroscience : MN, 11(3), 183-97. https://doi.org/10.1385/JMN:11:3:183
Aksenov, M., Tucker, H., Nair, P., Aksenova, M., Butterfield, D., Estus, S., & Markesbery, W. (1999). The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer’s disease. Neurochemical Research, 24(6), 767-74. https://doi.org/10.1023/a:1020783614031
Aksenova, M., Aksenov, M., Markesbery, W., & Butterfield, D. (1999). Aging in a dish: age-dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long-term hippocampal cell culture. Journal of Neuroscience Research, 58(2), 308-17. Retrieved from https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0360-4012&date=1999&volume=58&issue=2&spage=308 (Original work published 1999)
Keller, J., Lauderback, C., Butterfield, D., Kindy, M., Yu, J., & Markesbery, W. (2000). Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. Journal of Neurochemistry, 74(4), 1579-86. https://doi.org/10.1046/j.1471-4159.2000.0741579.x
Aksenov, M., Aksenova, M., Butterfield, D., & Markesbery, W. (2000). Oxidative modification of creatine kinase BB in Alzheimer’s disease brain. Journal of Neurochemistry, 74(6), 2520-7. https://doi.org/10.1046/j.1471-4159.2000.0742520.x
Lauderback, C., Hackett, J., Keller, J., Varadarajan, S., Szweda, L., Kindy, M., … Butterfield, D. (2001). Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer’s disease. Biochemistry, 40(8), 2548-54. https://doi.org/10.1021/bi002312k (Original work published 2001)
Lauderback, C., Hackett, J., Huang, F., Keller, J., Szweda, L., Markesbery, W., & Butterfield, D. (2001). The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer’s disease brain: the role of Abeta1-42. Journal of Neurochemistry, 78(2), 413-6. https://doi.org/10.1046/j.1471-4159.2001.00451.x
Castegna, A., Aksenov, M., Aksenova, M., , Klein, J., Pierce, W., … Butterfield, D. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine, 33(4), 562-71. https://doi.org/10.1016/s0891-5849(02)00914-0 (Original work published 2002)
Castegna, A., Aksenov, M., , Klein, J., Pierce, W., Booze, R., … Butterfield, D. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal of Neurochemistry, 82(6), 1524-32. https://doi.org/10.1046/j.1471-4159.2002.01103.x